| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3847693 | American Journal of Kidney Diseases | 2014 | 10 Pages |
Abstract
At equal BP levels, we found that irbesartan treatment did not affect the decline in GFR or urine volume significantly during 1 year of treatment in HD patients. Irbesartan treatment was used safely in the studied population.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Krista Dybtved MD, PhD, Christian Daugaard MD, PhD, Bente MD, DrMedSc, Ida Nørager MD, PhD, Jens Kristian MD, PhD, Birgitte Bang MD, PhD, Marija Kristina MD, Kathrine Skaaning MD, Bo Martin PhD, Charlotte MD, Jens Dam MD, PhD,